SGP launch Health Economics analysis
July 2017: Health Economics analysis gets underway to evaluate Whole Genome Sequencing for diagnostics in NHS Scotland.
The Scottish Genomes Partnership (SGP), co-directed by CGEM’s Professor Tim Aitman, has launched a research project which will evaluate the effectiveness of Whole Genome Sequencing (WGS) as an intervention within NHS Scotland genetics services.
Working in collaboration with the Health Economics Research Unit (HERU) at the University of Aberdeen, the analysis will assess the costs and benefits of WGS for the diagnosis of rare disorders, in comparison to other potential health care interventions. The evaluation will form the basis of recommendations about the use of Whole Genome Sequencing within the Scottish NHS.
Please visit the Scottish Genomes Partnership website for the full story.